Improving long-acting HIV treatments for young people
Optimizing the Use of Long-Acting Antiretrovirals for Youth Living withHIV
This study is looking at ways to help young people aged 13 to 29 with HIV stick to their long-acting treatments, by understanding what challenges they face and finding better ways to support them, so they can live healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10894942 on NIH RePORTER |
What this research studies
This research focuses on enhancing the use of long-acting antiretrovirals (LAARV) for youth aged 13 to 29 living with HIV, who often face challenges in adhering to treatment. The project aims to understand the various factors that affect treatment success, including mental health, cognitive abilities, and social circumstances. By developing and testing new methods for monitoring treatment adherence, the research seeks to create effective interventions that can help these young individuals benefit from LAARV. The ultimate goal is to improve health outcomes and reduce disparities in HIV care among this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth aged 13 to 29 who are living with HIV and experiencing difficulties with treatment adherence.
Not a fit: Patients outside the age range of 13 to 29 or those not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment adherence and health outcomes for young people living with HIV.
How similar studies have performed: Previous research has shown promise in using long-acting antiretrovirals for improving adherence in various populations, indicating potential success for this approach in youth.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Weld, Ethel Derby — Johns Hopkins University
- Study coordinator: Weld, Ethel Derby
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.